Notice of Intent to Sole Source_24Q0046.pdf

PDF 65 KB Posted

Attached to
Notice of Intent to Sole-Source: FA4626-24-Q-0046
Solicitation number
FA4626-24-Q-0046
Issued by

About this file

This document is a Notice of Intent to Sole-Source for Solicitation FA4626-24-Q-0046 issued by the 341st Contracting Squadron at Malmstrom Air Force Base, Montana. The government intends to award a sole-source contract to Ortho Clinical Diagnostics to provide preventive maintenance, administrative support, reagents, controls, calibrators, transportation, and a new chemical analyzer with consumables for the 341st Medical Group. Ortho Clinical Diagnostics is the sole manufacturer and source for the required operating systems, devices, and chemistry analyzer. The contract would have a 12-month base period and three 1-year option periods from October 1, 2024 through September 30, 2028. The government also seeks to transfer ownership of the current chemistry analyzer. Responsible sources may submit capability statements, proposals, or quotations to the specified contracting personnel by July 17, 2024 at 2:00 PM MST, showing how competition would be advantageous to the government.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

NOTICE OF INTENT TO SOLE-SOURCE

MALSTROM AFB

FA4626-24-Q-0046

Notice of Intent to Sole-Source: The 341st Contracting Squadron (CONS) – Malmstrom Air Force

Base, Montana intends to award, on a sole-source basis, a contract to Ortho Clinical Diagnostics to perform preventive maintenance, administrative support, reagents, controls, calibrators, and transportation necessary to perform the services for the Chemistry Analyzer for the 341st Medical

Group (MDG). Additionally, Ortho Clinical Diagnostics will provide a chemical analyzer and consumables. Lastly, the Government seeks to transfer ownership of the current chemical analyzer utilized by the 341 MDG. The period of performance consists of a base period of 12-months and three 1-year option periods from 1 October 2024 through 30 September 2028.

Ortho Clinical Diagnostics is the sole manufacturer/source provider for their operating systems, devices, and any chemistry analyzer units made/sold by Ortho Clinical Diagnostics. Ortho Clinical

Diagnostics holds multiple patents on dry slide technology and other technologies (wet chemistry) are not compatible due to the location of the analyzer, limited access to drains, and the need for a water system. Only consumables and parts procured from Ortho Clinical as the original equipment manufacturer (OEM) are suitable as reagents, and replacement parts and OEM consumables and parts are available only through Ortho Clinical authorized technicians and representatives.

THIS IS NOT A REQUEST FOR COMPETITIVE OFFERS and a solicitation will not be issued.

All responsible sources may submit a quote which shall be considered. Any response to this notice must show clear and convincing evidence that competition of this requirement would be advantageous to the Government. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. If no affirmative written response is received, the award will be made without further notice. Oral communications are not acceptable in response to this notice. RESPONSES ARE DUE NO LATER THAN 17 July 2024 by 2:00 PM

MST at 341 CONS, Malmstrom AFB to the attention of the following: Ms. Karen Broughton, Contract Specialist, karen.broughton@us.af.mil., Mrs. Viviana Castillo-Ramirez, Contracting Officer, viviana.castillo_ramirez@us.af.mil, and Mr. Eric Hallberg at erik.hallberg@us.af.mil, and

341cons.pkb.admin@us.af.mil.

mailto:karen.broughton@us.af.mil.

mailto:viviana.castillo_ramirez@us.af.mil mailto:erik.hallberg@us.af.mil mailto:341cons.pkb.admin@us.af.mil

File details come from the government source that posted it. Updated .